• Mashup Score: 0

    Objective To investigate the occurrence of cardiovascular events (CVEs) in a large cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across the European Union, China, Turkey, Russia, the United Kingdom, and the USA. Methods Patients with a definite diagnosis of AAV who were followed for ≥ 3 months and had sufficient documentation were included. Data on myocardial infarction (MI) and stroke were collected retrospectively from tertiary vasculitis centers. Univariate and multivariate Cox regression models were used to estimate hazard ratios (HRs) and 95% CIs. Results Over a median follow-up of 62.0 months (IQR 22.6-100.0), CVEs (mostly MIs) occurred in 245 (10.7%) of 2286 patients with AAV, with a higher frequency in China and the UK. On multivariate regression analysis, older age (55-64.9 yrs, HR 2.93, 95% CI 1.99-4.31), smoking (HR 1.98, 95% CI 1.48-2.64), Chinese origin (HR 4.24, 95% CI 3.07-5.85), and pulmonary (HR 1.50, 95% CI 1.09-2.06) a

    Tweet Tweets with this article
    • Research Article Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study 📰 https://t.co/z9KodSm78w #vasculitis #cardiovascular #myocardialinfarction #stroke https://t.co/ng3lIdGOL3

  • Mashup Score: 0

    Premature atherosclerosis has been observed during the course of different systemic inflammatory diseases, such as rheumatoid arthritis (RA), systemic lupus erythematosus, and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).1-3 As a result, cardiovascular (CV) events, including myocardial infarction, stroke, heart failure, coronary artery disease, and death, occur 1.65 to 3 times more commonly in patients with AAV as compared to the general population, and the risk appears to be highest in the first year following diagnosis.3 After the first year, however, CV disease (CVD) remains the most important cause of death besides malignancy and infection. It has been demonstrated that traditional risk factors for CVD, such as hypertension, dyslipidemia, diabetes, age, and a family history of CVD, are highly prevalent in AAV. In this issue of The Journal of Rheumatology , Moiseev et al demonstrated that smoking and pulmonary involvement were also associated with an increa

    Tweet Tweets with this article
    • Editorial For Your Eyes Only: 007 Tips for the Management of Cardiovascular Risk Factors in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis 📰 https://t.co/uzKj4MlRps #vasculitis #cardiovascular #myocardialinfarction #riskfactors #stroke https://t.co/vTZQY5wH0f

  • Mashup Score: 0
    Vasculitis - 8 month(s) ago

    About this Quiz Answer questions and review cases on these topics and more. Leukocytoclastic vasculitis Giant cell arteritis Granulomatosis with polyangiitis Below are sample questions you can expect to see in this quiz. Which of the following autoimmune condition is most associated with the development of cryoglobulinemic vasculitis? …

    Tweet Tweets with this article
    • The current high score on our vasculitis topic quiz is 77%. Can YOU beat it? https://t.co/xns7VAoxWT #Rheumatology #RheumandBoards #Vasculitis https://t.co/1wcbuqlO0D

  • Mashup Score: 2

    Hypereosinophilic syndrome (HES) is a disease with diverse clinical presentations including cardiac, neurologic, cutaneous, or pulmonary manifestations.1 We present a case of a 64-year-old man, active smoker, with history of occasional cocaine use who visited the emergency department because of progressive darkening of fingertips for 2 weeks, accompanied by intense pain and aggravated by cold temperature. Physical examination showed ischemia of all fingertips bilaterally, with necrosis of left index, middle, and annular fingers and right middle finger (Figure 1, A), associated with decreased temperature and tenderness to palpation.

    Tweet Tweets with this article
    • In Current Issue (FREE)! #Digital #Ischemia as a Presenting Feature of #Hypereosinophilic #Syndrome-Associated #Vasculitis https://t.co/YGyfugsev1

  • Mashup Score: 0
    Home - 8 month(s) ago

    THE VENETIAN LAS VEGAS LAS VEGAS, NEVADA This year we’ re leaving screens completely behind and meeting in person because Perspectives in Rheumatic Diseases (PRD) is more than a conference – we’ re a community. For us, joining together again is an opportunity to enhance the learning experience. As always, our renowned faculty will bring you the latest advancements in rheumatic diseases, from rheumatoid arthritis, lupus, and vasculitis to spondylitis, on top of other urgent issues for practitioners. We

    Tweet Tweets with this article
    • ⌛ ONE WEEK LEFT: #PRDlive23. Learn the latest advancements in rheumatic diseases, from #rheumatoid #arthritis, #lupus, and #vasculitis to #spondylitis and much more. Register now: https://t.co/kbaAX80WOD https://t.co/JjGaVZCbxr

  • Mashup Score: 2

    From 1 September, rheumatology services must begin entering patients with a confirmed diagnosis of Connective Tissue Disease (CTD) or Systemic Vasculitis int…

    Tweet Tweets with this article
    • From 1 Sep, rheumatology services must enter patients with confirmed diagnosis of Connective Tissue Disease/Systemic #Vasculitis into the National Early Inflammatory Arthritis Audit. Dr Liz Price and Dr @lanyon_peter discuss the significance https://t.co/EOeIVVGLz6 #NEIAA #CTD https://t.co/OfQrrJ6x4X

  • Mashup Score: 0
    Wolters Kluwer Health - 10 month(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Does the duration of #corticosteroid treatment impact Temporal artery biopsy positivity in patients with suspected #GCA? https://t.co/jCTsrmADuf #vasculitis #rheumtwitter https://t.co/0SZPzN4CXh

  • Mashup Score: 0
    Home - 10 month(s) ago

    This year we’re leaving screens completely behind and meeting in person because Perspectives in Rheumatic Diseases (PRD) is more than a conference–we’re a community. For us, joining together again is an opportunity to enhance the learning experience. As always, our renowned faculty will bring you the latest advancements in rheumatic diseases, from rheumatoid arthritis, lupus, and vasculitis to…

    Tweet Tweets with this article
    • 🆕 CONFERENCE ALERT 🚨 DON'T MISS #PRDlive23. Learn the latest advancements in rheumatic diseases, from #rheumatoid #arthritis, #lupus, and #vasculitis to #spondylitis and much more. Register now: https://t.co/B83jqfNDWX https://t.co/9beF63pvQ1

  • Mashup Score: 0

    July 01, 2023; Volume 50,Issue 7 Review Osteolysis in Systemic Sclerosis: A Scoping ReviewMiguel Gomes Guerra, Mariana Rodrigues, Ana Águeda, Joana Rodrigues, José Marona, António Violante and Margarida Oliveira The Journal of Rheumatology July 1 2023, 50 (7) 863-872; DOI:…

    Tweet Tweets with this article
    • Welcome July! ⛱️ View the full issue online 👉 https://t.co/rqHIll75N7 #systemicsclerosis #rheumatoidarthritis #spondyloarthritis #vasculitis #pediatric #patients #rheumatology #rheumtwitter #jrheum50 https://t.co/GiFQBUE9RZ

  • Mashup Score: 0
    Home - 10 month(s) ago

    This year we’re leaving screens completely behind and meeting in person because Perspectives in Rheumatic Diseases (PRD) is more than a conference–we’re a community. For us, joining together again is an opportunity to enhance the learning experience. As always, our renowned faculty will bring you the latest advancements in rheumatic diseases, from rheumatoid arthritis, lupus, and vasculitis to…

    Tweet Tweets with this article
    • 🆕 CONFERENCE ALERT 🚨 DON'T MISS #PRDlive23. Learn the latest advancements in rheumatic diseases, from #rheumatoid #arthritis, #lupus, and #vasculitis to #spondylitis and much more. Register now: https://t.co/UIZ4RXH8xn https://t.co/SNNxZwaiVB